SINGAPORE, Nov. 9, 2024 /PRNewswire/ -- HistoIndex, a pioneering leader in artificial intelligence ...
* Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory...
* Company to deliver two oral and six poster presentations, including one TOP poster and one sele...
Data from MAESTRO-NASH study revealed that HistoIndex's technology identified larger percentage of ...
SINGAPORE, June 15, 2023 /PRNewswire/ -- HistoIndex has announced that its novel technology combin...
SINGAPORE, June 15, 2023 /PRNewswire/ -- Recent findings from the TANDEM study (NCT03517540) in 193...
Advancing ML/AI-based technology in the study of liver diseases by furthering strategic partnership...
SINGAPORE, Jan. 10, 2023 /PRNewswire/ -- The Board of Directors (the "Board") of HistoIndex (the "C...
SINGAPORE, July 29, 2022 /PRNewswire/ -- HistoIndex, a global leading artificial intelligence digit...
SINGAPORE, May 18, 2022 /PRNewswire/ -- HistoIndex
* This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine arti...
SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical...
SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical...
SINGAPORE, March 5, 2022 /PRNewswire/ -- Biobot Surgical is excited to announce U.S. FDA 510(k) cle...
SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- HistoIndex
SINGAPORE, Aug. 18, 2021 /PRNewswire/ -- HistoIndex
SINGAPORE, June 25, 2021 /PRNewswire/ -- HistoIndex
SINGAPORE, Jan. 25, 2021 /PRNewswire/ -- HistoIndex
* HistoIndex joins forces with a consortium of partners from NHS Health Boards, UK universities an...
SINGAPORE, Nov. 18, 2020 /PRNewswire/ -- HistoIndex